To ask Her Majesty's Government further to the Written Answer by Lord Darzi of Denham on 29 June (WA 14), what action Lord Darzi of Denham as a Minister has taken, in addition to his department contacting the Whips' Office, to secure a debate on their response to the Archer report. [HL4724]
I refer the noble Lord to my Answer of 3 June (Official Report, col. WA 92). The decision on whether to hold a debate on the government response to the Archer report remains a matter for the House business managers.
To ask Her Majesty's Government further to the Written Answer by Lord Darzi of Denham on 29 June (WA 14), whether they will review the point at which the widow of a patient infected with hepatitis C by contaminated NHS blood products becomes eligible for financial assistance. [HL4725]
To ask Her Majesty's Government what figures the Department of Health has on the number of haemophilia patients who died of hepatitis C infection from contaminated NHS blood products in each of the past five years; and, on the basis of those figures, what they anticipate could be the number of such deaths by 2014. [HL4726]
To ask Her Majesty's Government how many haemophilia patients infected with HIV by contaminated NHS blood products have died in each of the past five years; and, on the basis of those figures, what they anticipate could be the number of such deaths by 2014. [HL4768]
Information in the form requested is not available, and the department has made no estimates of future rates of death in this patient group.
The Macfarlane Trust, set up in 1988 to administer a fund for haemophiliacs infected with human immunodeficiency virus (HIV), provides the following data on deaths of infected patients, but these cannot necessarily be attributed to HIV as the cause of death is not recorded.
2004-05 10 2005-06 7 2006-07 9 2007-08 9 2008-09 11
There are no comparable data on hepatitis C. However the UK Haemophilia Doctors' Organisation Annual Report 2008 and Bleeding Disorder Statistics for 2007 records two deaths attributable directly to HIV and six to hepatitis C in bleeding disorder patients in 2007. The same report states that deaths from hepatitis C in this group of patients run at between six and eight each year, but does not provide similar information on deaths from HIV.